Complications associated with pegging hydroxyapatite orbital implants

Ophthalmology

Volumn 106, Issue 3, 1999, Pages 505-512

  Jordan, David R ^a,b   Chan, Stanley ^a   Mawn, Louise ^a   Gilberg, Steven ^a   Dean, Tom ^b   Brownstein, Seymour ^a   Hill, Vivian E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Medical School ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; HYDROXYAPATITE;

ARTICLE; CONJUNCTIVITIS; FOLLOW UP; GRANULATION TISSUE; HUMAN; MAJOR CLINICAL STUDY; ORBIT IMPLANT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PYOGENIC GRANULOMA; RETROSPECTIVE STUDY;

EID: 0033497556     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90108-2     Document Type: Article

References (26)

1. Perry AC. Advances in enucleation. Ophthal Plast Reconstr Surg 1991;4:1:173-82.
2. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
3. Jordan DR, Gilberg S, Mawn L, et al. The synthetic hydroxyapatite implant: a report on 65 patients. Ophthal Plast Reconstr Surg 1998;14:250-5.
4. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995;11: 2:77-88.
5. Byrd WA. Coralline hydroxyapatite orbital implants. Ophthalmic Practice 1991;9:262-6.
6. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1997;104:324-9.
7. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
8. Shields CL, Shields JA, DePotter P. Hydroxyapatite orbital implant after enucleation: experience with initial 100 consecutive cases. Arch Ophthalmol 1992;110:333-8.
9. Shields CL, Shields JA, De Potter P, Singh AD. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 1993;91:177-89.
10. De Potter P, Shields CL, Shields JA, Singh AD. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol 1994;112:208-12.
11. Kim YD, Goldberg RA, Shorr N, Steinsapir KD. Management of exposed hydroxyapatite orbital implants. Ophthalmology 1994;101:1709-15.
12. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669-73.
13. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants. Report of six cases. Ophthalmology 1992;99:831-6.
14. Ainbinder DJ, Haik BG, Tellado M. Hydroxyapatite orbital implant abscess: histopathologic correlation of an infected implant following evisceration. Ophthalmic Plast Reconstr Surg 1994;10:267-70.
15. Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994;78:702-6.
16. Kolberg GI. The hydroxyapatite (Bio-eye®) implant: a historical perspective. J Ophthalmic Prosthetics 1996;1:29-36.
17. Jordan DR, Brownstein S, Jolly SS. Abscessed hydroxyapatite orbital implants. A report of two cases. Ophthalmology 1996; 103:1784-7.
18. Shields CL, Shields JA, De Potter P. Hydroxyapatite orbital implant after enucleation for intraocular tumors. Int Ophthalmol Clin 1993;33:83-93.
19. Shields JA, Shields CL, De Potter P. Hydroxyapatite orbital implant after enucleation - experience with 200 cases. Mayo Clin Proc 1993;68:1191-5.
20. Remulla HD, Rubin PAD, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology 1995;102: 586-93.
21. Massry GG, Holds JB. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos. Ophthalmology 1995;102:161-6.
22. Jordan D. The popping peg phenomenon [letter]. Arch Ophthalmol 1994;112:300-1.
23. Edelstein C, Shields CL, De Potter P, Shields JA. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997;104:1616-20.
24. Ferrone PJ, Dutton JJ. Rate of vascularization of coralline hydroxyapatite ocular implants. Ophthalmology 1992;99: 376-9.
25. De Potter P, Shields CL, Shields JA, et al. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant. Ophthalmology 1992;99:824-30.
26. Popp JC. The use of Mitomycin C for the treatment of pyogenic socket granulation tissue associated with motility pegs. J Ophthalmic Pros 1996;1:25-7.